FreeTCCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer December 01, 2014Vol.37 No.11
FreeTCCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III December 01, 2014Vol.37 No.11
Drugs & TargetsFreeTCCL Archive FDA Approves Velcade Injection In Mantle Cell Lymphoma October 30, 2014Vol.37 No.10
FreeTCCL Archive Anamorelin Increases Body Mass in Two Global Phase III Trials October 30, 2014Vol.37 No.10
FreeTCCL Archive Zytiga and Prednisone Extends Overall Survival in mCRPC Trial October 30, 2014Vol.37 No.10
FreeTCCL Archive Afatinib Delays Tumor Growth in LUX-Head and Neck 1 Study October 30, 2014Vol.37 No.10
FreeTCCL Archive Study: Angiopoietin-2 Levels May Predict Lenvatinib Response October 30, 2014Vol.37 No.10
FreeTCCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 30, 2014Vol.37 No.10
FreeTCCL Archive Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial October 30, 2014Vol.37 No.10
